| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Anixa Biosciences, Inc. (ANIX) has 5 insiders with recent SEC Form 4 filings, including 11 buys and 4 sells. ANIX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 987.0K | $3.65M | +14.8K | |
| CEO | 640.8K | $2.37M | +10.0K | |
| CFO | 175.0K | $647.5K | - | |
| Dir | 135.0K | $499.5K | - | |
| Dir | 25.0K | $92.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2016 | Kumar Amit62 | Director | Buy | 2,000 | $2.46 | $4,920.00 | +1.0% | |
| Feb 29, 2016 | Titterton Lewis H Jr65 | Director | Buy | 2,000 | $2.29 | $4,580.00 | +0.4% | |
| Oct 30, 2015 | Herms Henry P | Vice President-finance &CFO | Sell | 500 | $3.76 | $1,880.00 | -2.2% | |
| Oct 29, 2015 | Herms Henry P | Vice President-finance &CFO | Sale+OE | 3,500 | $3.78 | $13,234.00 | -4.7% | |
| Sep 25, 2015 | Johnson Bruce F | Director | Buy | 1,400 | $4.49 | $6,286.00 | +0.3% | |
| Sep 25, 2015 | Titterton Lewis H Jr65 | Director | Buy | 5,616 | $4.59 | $25,777.44 | +1.1% | |
| Sep 25, 2015 | Kumar Amit62 | Director | Buy | 1,000 | $4.70 | $4,700.00 | +1.0% | |
| Sep 22, 2015 | Titterton Lewis H Jr65 | Director | Buy | 700 | $4.91 | $3,437.00 | - | |
| Sep 21, 2015 | Johnson Bruce F | Director | Buy | 100 | $5.15 | $515.00 | - | |
| Sep 18, 2015 | Titterton Lewis H Jr65 | Director | Buy | 681 | $5.28 | $3,597.90 | - |